BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1493919)

  • 21. Effect of soluble P55 tumour-necrosis factor binding fusion protein on the local Shwartzman and Arthus reactions.
    Norman KE; Williams TJ; Feldmann M; Rossi AG
    Br J Pharmacol; 1996 Feb; 117(3):471-478. PubMed ID: 8821536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and regulation of monocyte chemoattractant protein-1 in lipopolysaccharide- or monosodium urate crystal-induced arthritis in rabbits: roles of tumor necrosis factor alpha, interleukin-1, and interleukin-8.
    Matsukawa A; Miyazaki S; Maeda T; Tanase S; Feng L; Ohkawara S; Yoshinaga M; Yoshimura T
    Lab Invest; 1998 Aug; 78(8):973-85. PubMed ID: 9714185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of TNF alpha, IL-1 beta and IL-1 receptor antagonist in LPS-induced rabbit uveitis.
    Mo JS; Matsukawa A; Ohkawara S; Yoshinaga M
    Exp Eye Res; 1998 May; 66(5):547-57. PubMed ID: 9628802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer.
    Gouze JN; Gouze E; Palmer GD; Liew VS; Pascher A; Betz OB; Thornhill TS; Evans CH; Grodzinsky AJ; Ghivizzani SC
    Arthritis Res Ther; 2003; 5(5):R301-9. PubMed ID: 12932294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist.
    Henderson B; Thompson RC; Hardingham T; Lewthwaite J
    Cytokine; 1991 May; 3(3):246-9. PubMed ID: 1832054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist.
    Cunha JM; Cunha FQ; Poole S; Ferreira SH
    Br J Pharmacol; 2000 Jul; 130(6):1418-24. PubMed ID: 10903985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
    Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
    Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector.
    Roessler BJ; Hartman JW; Vallance DK; Latta JM; Janich SL; Davidson BL
    Hum Gene Ther; 1995 Mar; 6(3):307-16. PubMed ID: 7779914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist.
    Miller LC; Isa S; Vannier E; Georgilis K; Steere AC; Dinarello CA
    J Clin Invest; 1992 Sep; 90(3):906-12. PubMed ID: 1387885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia.
    Jansen PM; Boermeester MA; Fischer E; de Jong IW; van der Poll T; Moldawer LL; Hack CE; Lowry SF
    Blood; 1995 Aug; 86(3):1027-34. PubMed ID: 7620156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide, but not interleukin-1, mediates the local blood flow response to lipopolysaccharide in rabbit skin.
    Pons F; Williams TJ; Warren JB
    Eur J Pharmacol; 1993 Aug; 239(1-3):23-30. PubMed ID: 8223899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans.
    Granowitz EV; Porat R; Mier JW; Orencole SF; Callahan MV; Cannon JG; Lynch EA; Ye K; Poutsiaka DD; Vannier E
    Blood; 1993 Nov; 82(10):2985-90. PubMed ID: 8219190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit.
    Arner EC; Harris RR; DiMeo TM; Collins RC; Galbraith W
    J Rheumatol; 1995 Jul; 22(7):1338-46. PubMed ID: 7562769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of exogenous prostaglandin E2 and actinomycin D on plasma leakage induced by neutrophil-activating peptide-1/interleukin-8.
    Colditz IG
    Immunol Cell Biol; 1990 Dec; 68 ( Pt 6)():397-403. PubMed ID: 2097295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus induces GM-CSF synthesis by monocytes: effect on EBV-induced IL-1 and IL-1 receptor antagonist production in neutrophils.
    Roberge CJ; Larochelle B; Rola-Pleszczynski M; Gosselin J
    Virology; 1997 Nov; 238(2):344-52. PubMed ID: 9400607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bovine neutrophil chemiluminescence is preferentially stimulated by homologous IL-1, but inhibited by the human IL-1 receptor antagonist.
    Sample AK; Czuprynski CJ
    Vet Immunol Immunopathol; 1994 May; 41(1-2):165-72. PubMed ID: 8066992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.
    Tang WW; Feng L; Vannice JL; Wilson CB
    J Clin Invest; 1994 Jan; 93(1):273-9. PubMed ID: 7904269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-4-induced eosinophil accumulation in rat skin is dependent on endogenous TNF-alpha and alpha 4 integrin/VCAM-1 adhesion pathways.
    Sanz MJ; Marinova-Mutafchieva L; Green P; Lobb RR; Feldmann M; Nourshargh S
    J Immunol; 1998 Jun; 160(11):5637-45. PubMed ID: 9605170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteria.
    Porzio S; Bossù P; Ruggiero P; Boraschi D; Tagliabue A
    BMC Biotechnol; 2004 Oct; 4():27. PubMed ID: 15516267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human recombinant interleukin-1 receptor antagonist (hrIL-1RA) inhibits prostaglandin E2 (PGE2) generation but not alkaline phosphatase activity in in vivo chronic granulomatous tissue induced by KMnO4.
    Conti P; Barbacane RC; Felaco M; Grilli A; Placido FC; Reale M
    Immunol Lett; 1993 Jul; 37(1):1-6. PubMed ID: 8225402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.